BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Prostate
,
DNA fingerprint
,
Lovastatin
,
rs2300478
,
DNMT1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
melanoma cells
Summary
General Info
Curated Studies
Most Correlated Studies
GSK cancer cell line transcript profiling
Amelanotic melanoma A375M2 and C32 cell lines with PMEL expression and FHL2 or NFYA shRNA knockdown
Melanoma cell line gene expression in response to 2Gy exposure to carbon ions or X-rays
SkMel30 melanoma cells expressing HOXA1
Uvela melanoma cells BETi resistant treated with PLX51107
Explore Curated Studies Results
Literature
Most Relevant Literature
Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regula…
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression…
Identification of Melanoma-reactive CD4+ T-Cell Subsets From Human Melanoma Draining Lymph Nodes.
Carnosic acid inhibits the epithelial-mesenchymal transition in B16F10 melanoma cells: a possible me…
Tumor-associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immun…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
Tracing Dissemination of Melanoma Cells in Healthy Tissues
Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer
Efficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene Aberrations
MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ